Cargando…

Home-based screening tools for amblyopia: a systematic review protocol

INTRODUCTION: Amblyopia is an important public health concern associated with functional vision loss and detrimental impact on the physical and mental well-being of children. The gold standard for diagnosis of amblyogenic conditions currently involves screening by orthoptists and/or ophthalmologists...

Descripción completa

Detalles Bibliográficos
Autores principales: Sii, Samantha, Chean, Chung Shen, Kuht, Helen J, Thomas, Mervyn G, Rufai, Sohaib R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404433/
https://www.ncbi.nlm.nih.gov/pubmed/34452969
http://dx.doi.org/10.1136/bmjopen-2021-051830
_version_ 1783746166327869440
author Sii, Samantha
Chean, Chung Shen
Kuht, Helen J
Thomas, Mervyn G
Rufai, Sohaib R
author_facet Sii, Samantha
Chean, Chung Shen
Kuht, Helen J
Thomas, Mervyn G
Rufai, Sohaib R
author_sort Sii, Samantha
collection PubMed
description INTRODUCTION: Amblyopia is an important public health concern associated with functional vision loss and detrimental impact on the physical and mental well-being of children. The gold standard for diagnosis of amblyogenic conditions currently involves screening by orthoptists and/or ophthalmologists. The bloom of technology enables the use of home-based screening tools to detect these conditions at an early stage by the layperson in community, which could reduce the burden of screening in the community, especially during restrictions associated with the COVID-19 pandemic. Here, we propose a systematic review aiming to evaluate the accuracy and reliability of home-based screening tools compared with the existing gold standard. METHODS AND ANALYSIS: We aim to search for studies involving home-based screening tools for amblyopia among children aged under 18 years. Oxford Centre for Evidence-Based Medicine Level 4 evidence and above will be included, without language or time restrictions. The following platforms will be searched from inception to 31 August 2021: PubMed, Medline, The Cochrane Library, Embase, Web of Science Core Collection and Clinicaltrials.gov. Two independent reviewers will identify studies for inclusion based on a screening questionnaire. The search and screening will start on 14 August 2021 until 1 October 2021. We aim to complete our data analysis by 30 November 2021. Risk of bias will be assessed using the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool for diagnostic accuracy studies only. Our primary outcome measure is the diagnostic accuracy of home-based screening tools, while secondary outcome measures include validity, feasibility, reproducibility and cost-effectiveness, where available. ETHICS AND DISSEMINATION: Ethical approval is not necessary as no primary data will be collected. The findings will be disseminated through presentations at scientific meetings and peer-reviewed journal publication. PROSPERO REGISTRATION NUMBER: CRD42021233511.
format Online
Article
Text
id pubmed-8404433
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-84044332021-09-14 Home-based screening tools for amblyopia: a systematic review protocol Sii, Samantha Chean, Chung Shen Kuht, Helen J Thomas, Mervyn G Rufai, Sohaib R BMJ Open Ophthalmology INTRODUCTION: Amblyopia is an important public health concern associated with functional vision loss and detrimental impact on the physical and mental well-being of children. The gold standard for diagnosis of amblyogenic conditions currently involves screening by orthoptists and/or ophthalmologists. The bloom of technology enables the use of home-based screening tools to detect these conditions at an early stage by the layperson in community, which could reduce the burden of screening in the community, especially during restrictions associated with the COVID-19 pandemic. Here, we propose a systematic review aiming to evaluate the accuracy and reliability of home-based screening tools compared with the existing gold standard. METHODS AND ANALYSIS: We aim to search for studies involving home-based screening tools for amblyopia among children aged under 18 years. Oxford Centre for Evidence-Based Medicine Level 4 evidence and above will be included, without language or time restrictions. The following platforms will be searched from inception to 31 August 2021: PubMed, Medline, The Cochrane Library, Embase, Web of Science Core Collection and Clinicaltrials.gov. Two independent reviewers will identify studies for inclusion based on a screening questionnaire. The search and screening will start on 14 August 2021 until 1 October 2021. We aim to complete our data analysis by 30 November 2021. Risk of bias will be assessed using the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool for diagnostic accuracy studies only. Our primary outcome measure is the diagnostic accuracy of home-based screening tools, while secondary outcome measures include validity, feasibility, reproducibility and cost-effectiveness, where available. ETHICS AND DISSEMINATION: Ethical approval is not necessary as no primary data will be collected. The findings will be disseminated through presentations at scientific meetings and peer-reviewed journal publication. PROSPERO REGISTRATION NUMBER: CRD42021233511. BMJ Publishing Group 2021-08-27 /pmc/articles/PMC8404433/ /pubmed/34452969 http://dx.doi.org/10.1136/bmjopen-2021-051830 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Ophthalmology
Sii, Samantha
Chean, Chung Shen
Kuht, Helen J
Thomas, Mervyn G
Rufai, Sohaib R
Home-based screening tools for amblyopia: a systematic review protocol
title Home-based screening tools for amblyopia: a systematic review protocol
title_full Home-based screening tools for amblyopia: a systematic review protocol
title_fullStr Home-based screening tools for amblyopia: a systematic review protocol
title_full_unstemmed Home-based screening tools for amblyopia: a systematic review protocol
title_short Home-based screening tools for amblyopia: a systematic review protocol
title_sort home-based screening tools for amblyopia: a systematic review protocol
topic Ophthalmology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404433/
https://www.ncbi.nlm.nih.gov/pubmed/34452969
http://dx.doi.org/10.1136/bmjopen-2021-051830
work_keys_str_mv AT siisamantha homebasedscreeningtoolsforamblyopiaasystematicreviewprotocol
AT cheanchungshen homebasedscreeningtoolsforamblyopiaasystematicreviewprotocol
AT kuhthelenj homebasedscreeningtoolsforamblyopiaasystematicreviewprotocol
AT thomasmervyng homebasedscreeningtoolsforamblyopiaasystematicreviewprotocol
AT rufaisohaibr homebasedscreeningtoolsforamblyopiaasystematicreviewprotocol